DexCom Stock Target Price and Analyst Consensus

DXCM Stock  USD 131.52  0.81  0.62%   
The prevalent analyst and expert consensus on DexCom is Strong Buy with 18 strong buy estimates. The prevailing projected target price is 137.00 with 24 professional opinions. Some of the most common ways DexCom Inc analysts use to provide public buy-or-sell recommendation are financial statements evaluation and conference calls analysis. They also talk to DexCom executives, vendors, and customers. DexCom buy-or-sell recommendation and consensus module provides average expert sentiment on the projected DexCom Inc target price to derive its highest and lowest estimates based on target price volatility of 0.0. Check out Macroaxis Advice on DexCom to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
124.67
Highest Forecast
152.07
Target Price
137
As of the 23rd of April 2024, Gross Profit is likely to grow to about 2.4 B. Also, Pretax Profit Margin is likely to grow to 0.21. At this time, DexCom's Total Current Assets are very stable compared to the past year. As of the 23rd of April 2024, Other Current Liabilities is likely to grow to about 1.3 B, while Other Current Assets are likely to drop about 25.1 M.
  
It's important to approach DexCom's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize DexCom price targets

DexCom's stock target price is an estimate of its future price, usually made by analysts. Using DexCom's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at DexCom's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if DexCom's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional DexCom Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of DexCom is a key component of DexCom valuation and have some predictive power on the future returns of a DexCom.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
128.72131.02133.32
Details
Intrinsic
Valuation
LowRealHigh
131.30133.60135.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.210.270.34
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DexCom. Your research has to be compared to or analyzed against DexCom's peers to derive any actionable benefits. When done correctly, DexCom's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DexCom Inc.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested a lot of shares
Chemicals Idea
Chemicals
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
ESG Investing Idea
ESG Investing
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 70 shares
Momentum Idea
Momentum
Invested over 200 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out Macroaxis Advice on DexCom to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
The data published in DexCom's official financial statements usually reflect DexCom's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DexCom Inc. For example, before you start analyzing numbers published by DexCom accountants, it's critical to develop an understanding of what DexCom's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of DexCom's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DexCom's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DexCom's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DexCom Inc. Please utilize our Beneish M Score to check the likelihood of DexCom's management manipulating its earnings.